JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

非阻害性多動性心筋症における心臓バイオマーカーのマヴァカメン効果: ODYSSEY- HCM試験からの洞察

  • 0Hypertrophic Cardiomyopathy Center, Cleveland Clinic, Cleveland, Ohio, USA; Cleveland Clinic Coordinating Center for Clinical Research, Heart Vascular Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Journal of the American College of Cardiology +

|

2025年8月27日

|

2025年8月27日

PubMedで要約を見る

まとめ

この要約は機械生成です。

マヴァカムテンは48週間にわたって非阻害性多動性心筋病 (nHCM) の患者でNT-proBNPとhs- cTnIのバイオマーカーを著しく減少させた. これらのバイオマーカーの変化が長期的な患者のアウトカムを改善するかどうかを確認するには,さらなる研究が必要です.

科学分野

  • 心臓病科
  • 薬理学について
  • バイオマーカーの研究

背景

  • 症状性非阻害性心筋縮症 (nHCM) に対して承認された治療法は存在しない.
  • ODYSSEY- HCM試験では,nHCMにおけるマヴァカメンを評価したが,機能能力や健康状態の主要なエンドポイントを満たさなかった.

研究 の 目的

  • nHCMにおける臨床的特徴を持つベースラインバイオマーカー関連 (NT-proBNP,hs-cTnI) を分析する.
  • nHCM患者におけるマヴァカメンとプラセボ群の生体マーカーの変化をベースラインから48週まで比較する.

主な方法

  • 症状のあるnHCM患者におけるマバカメンのランダム化プラセボ対照試験
  • バイオマーカー (NT-proBNP,hs-cTnI) と臨床/エコーカルディオグラフィのパラメータは,ベースラインと48週で測定された.

主要な成果

  • nHCM患者で観察されたNT-proBNPとhs- cTnIの上昇.
  • マバカメン群では,NT-proBNP (58%) とhs- cTnI (51%) が48週までに著しく減少した.
  • プラセボ群では有意なバイオマーカー変化は見られなかった.

結論

  • マバカメン治療は48週間にわたってnHCM患者で重要なバイオマーカーの改善をもたらしました.
  • これらのバイオマーカーの変化が長期的なアウトカムに与える臨床的意義については,さらなる調査が必要である.

キーワード:

関連する概念動画

Cardiomyopathy III: Hypertrophic Cardiomyopathy 01:29

45

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy V: Interprofessional Care 01:29

32

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy IV: Restrictive Cardiomyopathy 01:29

27

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy II: Dilated Cardiomyopathy 01:30

21

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers 01:20

332

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Acute Coronary Syndrome III: Diagnostic Studies 01:30

23

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...